Activated changes of platelet ultra microstructure and plasma granule membrane protein 140 in patients with non-small cell lung cancer

Chinese Medical Journal

Volumn 122, Issue 9, 2009, Pages 1026-1031

  Zhuge, Yi ^a   Zhou, Jian Ying ^b   Yang, Guang Die ^b   Zu, De Ling ^c   Xu, Xiao Liang ^d   Tian, Ming Qing ^c   Lu, Guo Hua ^b  

^a QUZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Quzhou People's Hospital   (China)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

granule; Granule membrane protein 140; Non small cell lung cancer; P selectin; Platelet; Ultra microstructure

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; SCANNING TRANSMISSION ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE;

ADULT; AGED; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; P-SELECTIN; SURVIVAL ANALYSIS;

EID: 68149125609     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.09.005     Document Type: Article

References (20)

1. 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer. Chin Med J 2007; 120: 125-131.
2. Wisnivesky JP, Yankelevitz D, Henschke CI. Stage of lung cancer in relation to its size. Chest 2005; 127: 1136-1139.
3. Roselli M, Mineo TC, Basili S, Mariotti S, Martini F, Bellotti A, et al. Vascular endothelial growth factor (VEGF-A) plasma levels in NSCLC: relationship with coagulation and platelet activation markers. Thromb Haemost 2003; 89: 177-184.
4. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005; 113: 752-760.
5. Gunay Aygun M, Huinzing M, Gahl WA. Molecular defects that affect platelet dense granules. Semin Thromb Hemost 2004; 30: 537-547.
6. Koda M, Banno Y, Naganawa T. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets. Platelets 2005; 16: 482-491.
7. Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 1998; 95: 9325-9330.
8. Xie GS, Hou AR, Li LY, Gao YN, Cheng SJ. Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer. Chin Med J 2006; 119: 1469-1472.
9. Li HL, Wang TS, Li XY, Li N, Huang DZ, Chen Q, et al. Overexpression of cyclin L2 induces apoptosis and cell-cycle arrest in human lung cancer cells. Chin Med J 2007; 120: 905-909.
10. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
11. Hartwig JH. Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118: 1421-1442.
12. Tan KT. Lip GY. The assessment of platelet activation in antiplatelet drug development. Curr Med Chem 2005; 12: 3117-3125.
13. Honn KV, Tang DG, Crissman JD. Platelet and metastasis: a causal relationship. Cancer Metastasis Rev 1992; 11: 325.
14. Fang L, Yan Y, Komuves LG, Yonkovich S, Sullivan CM, Stringer B, et al. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol 2004; 24: 787-792.
15. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7: 52-62.
16. Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, et al. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 2001; 4: 37-43.
17. Lages B, Sussman II, Levine SP, Coletti D, Weiss HJ. Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (alpha-storage pool deficiency). J Lab Clin Med 1997; 129: 364-375.
18. Ishihara Y, Nishikawa T, Iijima H, Matsunaga K. Expression of matrix metalloproteinase, tissue inhibitors of metallo-proteinase and adhesion molecules in silicotic mice with lung tumor metastasis. Toxicol Lett 2003; 142: 71-75.
19. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, et al. The functional role of blood platelet components in angiogenesis. Thromb Haemost 2004; 92: 394-402.
20. Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L. Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer. Chin Med J 2006; 119: 63-68.